Should You Accumulate Satsuma Pharmaceuticals Inc (STSA) Stock Monday Morning?

Monday, April 24, 2023 07:50 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Accumulate Satsuma Pharmaceuticals Inc (STSA) Stock Monday Morning?

Satsuma Pharmaceuticals Inc (STSA) is lower by Monday morning, with the stock falling -1.92% in pre-market trading to 1.02. STSA's short-term technical score of 42 indicates that the stock has traded less bullishly over the last month than 58% of stocks on the market. In the Biotechnology industry, which ranks 113 out of 146 industries, STSA ranks higher than 53% of stocks. Satsuma Pharmaceuticals Inc has risen 16.85% over the past month, closing at $0.85 on March 27. During this period of time, the stock fell as low as $0.66 and as high as $1.47. STSA has an average analyst recommendation of Buy. The company has an average price target of $2.00.

STSA has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on STSA!

See Full STSA Report

Satsuma Pharmaceuticals Inc has a Long-Term Technical rank of 52. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 48% of the market scoring higher. In the Biotechnology industry which is number 102 by this metric, STSA ranks better than 102% of stocks.

Important Dates for Investors in STSA:

-Satsuma Pharmaceuticals Inc is set to release earnings on 5/9/2023. Over the last 12 months, the company has reported EPS of $-2.20. -We do not have a set dividend date for Satsuma Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Satsuma Pharmaceuticals Inc (STSA)